January 23, 2025

CSEM and TheraMe! revolutionize cancer therapy with personalized drug screening technology

  • TheraMe! is a Lausanne-based medtech start-up at the forefront of advancing cancer treatment
  • TheraMe! employs proprietary microfluidic technologies to test the efficacy of cancer drugs on patients' tumor cells to determine the best therapy recommendation before treatment starts.
  • Together with CSEM, TheraMe! develops an instrument that analyzes live tumor samples to identify the best drug combinations for individual cancer patients
Group of 7 persons, members of the CSEM and the TheraMe teams
© CSEM - (from left to right) Mehmet SEHIR, Vida VAFAIZADEH, Hana SAMET (all TheraMe!), Christoph MERTEN (EPFL), Gilles WEDER and Baris ATAKAN (both CSEM) and Ngoc-Hien DU (TheraMe!)

Additional information

CSEM

Gilles WEDER
Head Research & BD, Life Sciences
gilles.weder@csem.ch

TheraMe!

Hana SAMET
Co-Founder and CTO
hana.samet@thera-me.ch

CSEM Media Relations

Sabina MÜLLER
Media Relations
media@csem.ch
T. +41 79 361 50 12

Press Release (EN)
Instrument developed in collaboration within 2 industrial projects.
Download
Hand holding a 24-channel labware
Download
Next fully integrated and functional device
Download
3 persons in a lab, looking at a technical device
Download

Related Press

Alithea team

16 May 2023

Democratizing RNA sequencing: A breakthrough in cost and efficiency

CSEM helped Alithea Genomics to create a technique that can handle hundreds of RNA samples in a single tube, resulting in a significant decrease in reagents and manual effort in the overall workflow....

A hand holding a bioreactor to grow vein grafts developed by CSEM and ClexBio

22 February 2024

CSEM and ClexBio create a bioreactor for tissue-engineered cardiovascular implants

The teams at CSEM and at ClexBio have developed a process for engineering vein grafts comprised of human tissue material that integrates into the patient’s body and can turn into real, living tissue....

Biospectal app

11 January 2021

Biospectal Announces Public Beta Launch Of OptiBP™

Biospectal’s OptiBP smartphone app and data platform empowers people worldwide with a medical-grade device integrated directly into their smartphone, enabling instantaneous blood pressure measurement ...